Head-to-head · WeighScore
Defy Medical vs Direct Meds
By GLP-1 ScorecardUpdated
Score comparison
Direct Meds has the higher recorded score — 77.6/100 to 60.2/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.
Before you choose
Defy Medical does not publish a semaglutide price, so its Defy Medical review sets out what it does disclose, while the Direct Meds review explains the conditions attached to Direct Meds's figure. The semaglutide cost page compares published rates across the field. Ask Defy Medical for a written total before treating either one as the cheaper choice.
If neither one fits, Defy Medical vs Invigor Medical and Direct Meds vs Dr. Arevitalize compare each of them with another graded program, and the list of alternatives to Defy Medical ranks the programs closest to Defy Medical on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Defy Medical | Direct Meds |
|---|---|---|
| WeighScore | 60.2/100 | 77.6/100 |
| Grade | C | C+ |
| Site position | #355 | #33 |
| Semaglutide | All-in price not published | $249/30 days sublingual · $297/mo injectable |
| Tirzepatide | All-in price not published | $299/30 days sublingual · $399/mo injectable |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Yes |
Strengths
- Weight-loss page names semaglutide, tirzepatide and liraglutide
- Terms explain visit and lab refund conditions
What to consider
- Public program pages do not establish an all-in price
- A consultation does not become refundable solely because no prescription is recommended
Site position #33 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Injection and sublingual preparations have separately published prices
- Pricing page advertises medication, evaluation, supplies, shipping and nurse access
- Both semaglutide and tirzepatide are listed
- Checked semaglutide campaign states $147 initially, then $297 monthly
What to consider
- Compounded preparations are not FDA-approved products or assumed equivalent across routes
- No-subscription FAQ wording conflicts with the agreement's 30-day recurring charges
- Renewal cancellation requires 48-hour notice; initial-order cancellation has a separate conditional 24-hour window
- Assigned prescribing practice, dispensing pharmacy and selected longer-plan total need confirmation
- Checked campaign excludes Mississippi and Louisiana; confirm state eligibility
Featured provider
Direct Meds
Direct Meds scores 77.6/100 (C+). Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.